iPSC

Japan Approves World’s First iPSC Therapies, Reshaping Global Biotech Competition

Commercial authorization for Cuorips and Sumitomo Pharma products validates 20-year development timeline and accelerates regulatory pathways across Asia-Pacific as U.S. and EU lag.